Phase III study of cisplatin with pemtrexed or vinorelbine plus concurrent late course accelerated hyperfractionated radiotherapy in patients with unresectable stage III non-small cell lung cancer

Our aim was to evaluate the efficacy and safety of cisplatin with pemtrexed or vinorelbine and concurrent late course accelerated hyperfractionated radiotherapy (LCAHRT). Patients with unresectable stage III non-small-cell lung cancer (NSCLC) were randomly assigned to two regimens. The experimental...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Oncotarget
Päätekijät: Zhao, Qian, Wang, Zhongtang, Huang, Wei, Wang, Qiang, Yu, Shuzeng, Zhou, Tao, Han, Dan, Wu, Zhenying, Gong, Heyi, Sun, Hongfu, Zhang, Jian, Wei, Yumei, Li, Hongsheng, Zhang, Zicheng, Lin, Haiqun, Li, Baosheng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Impact Journals LLC 2016
Aiheet:
Clinical Research Paper
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4885003/
https://ncbi.nlm.nih.gov/pubmed/26761213
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.6871
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia